novartis ceo on acquisitions, ai, weight-loss drugs
Published 7 months ago • 18K plays • Length 4:19Download video MP4
Download video MP3
Similar videos
-
3:45
novartis not joining the 'frenzy' of weight loss drugs, ceo says
-
1:06
novartis ceo expects growth of more than 5%
-
14:58
weight-loss drug ozempic a 'medical breakthrough', but we won't be driven by fomo: novartis ceo
-
0:57
novartis global ceo vas narasimhan: ai's impact on pharma and clinical trial realities | n18s
-
1:27:55
what came before the big bang? | theory of embedded intelligence, bill mensch & bernardo kastrup
-
32:24
ep. 61 - vas narasimhan: how new data fit novartis’ growth plan
-
25:17
novartis ceo vas narasimhan: how to be a boss in an “unbossed” company
-
5:53
novartis expects 'strong momentum' going into second half, says ceo vasant narasimhan
-
1:40
novartis microsoft reimagining medicine using ai
-
2:53
novartis ceo on the development of ai tech in health care
-
1:47
novartis and microsoft bring the power of ai to every employee
-
4:17
novartis ceo: we expect our six key drugs to grow ahead of analyst expectations
-
0:45
novartis ceo: company set to become a pure play, innovative medicine business after sandoz spin off
-
7:01
novartis ceo: nations pulling back on health care spending ‘has long-term consequences'
-
1:27
vas narasimhan announcing the ai innovation lab.
-
1:05
novartis under fire over high-cost cancer treatment
-
6:12
novartis ceo: expect continued growth in 2023
-
3:29
novartis generated $40 billion in innovative medicine sales, says ceo
-
3:04
novartis ceo: spinoffs will see us succeed as a pure-play innovative medicines company
-
16:06
vitalia interview: sebastian a. brunemeier - walking the longevity talk
-
4:22
novartis ceo on new cancer therapy programs